Green Thumb's Q3 Net Income Soars 170%, Cash Reserves Bolstered

TL;DR

**GTBIF's Q3 net income exploded, but the year-to-date picture is mixed; watch for sustained profitability and federal policy shifts.**

AI Summary

Green Thumb Industries Inc. reported a significant increase in net income for the three months ended September 30, 2025, reaching $23.29 million, up from $8.62 million in the same period of 2024, representing a 170% increase. However, net income for the nine months ended September 30, 2025, decreased to $30.95 million from $60.40 million in 2024, a 48.8% decline. Revenue saw a modest increase, with net revenues of $291.37 million for the three months ended September 30, 2025, compared to $286.87 million in 2024, a 1.6% rise. For the nine-month period, net revenues grew to $864.17 million from $842.82 million, a 2.5% increase. The company's cash and cash equivalents significantly improved, rising to $226.21 million as of September 30, 2025, from $171.69 million at December 31, 2024. Operating activities generated $204.79 million in cash for the nine months ended September 30, 2025, a substantial increase from $151.85 million in 2024. Key changes include a $29.88 million net gain on divestitures of intellectual property and a $75.63 million investment in securities and associates during the nine-month period. Risks include the ongoing federal illegality of cannabis in the U.S. and intense competition from both legal and illicit markets. The strategic outlook focuses on sustainable, profitable growth and expanding its cannabis consumer packaged goods brands like &Shine and RYTHM.

Why It Matters

Green Thumb's strong Q3 net income growth, despite a nine-month decline, signals potential operational efficiencies and strategic divestitures that could benefit investors. The significant increase in cash and cash equivalents to $226.21 million provides a stronger financial cushion, potentially enabling further market expansion or share repurchases, which could boost shareholder value. In a highly competitive cannabis market, this financial stability and focus on branded products like 'RYTHM' and '&Shine' are crucial for maintaining market share against rivals and the illicit market. Employees and customers benefit from a more stable company, while the broader market watches for signs of sustained profitability in the evolving U.S. cannabis industry.

Risk Assessment

Risk Level: medium — The risk level is medium due to the inherent regulatory uncertainty of the cannabis industry, as cannabis remains illegal under U.S. federal law, posing a significant operational risk. While the company reported a strong Q3 net income increase of 170% to $23.29 million, the nine-month net income decreased by 48.8% to $30.95 million, indicating potential volatility in earnings. The company also faces intense competition from the illicit market and Farm Bill compliant hemp products, as stated in the 'Risk Factors' section.

Analyst Insight

Investors should closely monitor Green Thumb's Q4 and full-year 2025 results to assess if the Q3 net income surge is sustainable or an anomaly. Evaluate the impact of the $29.88 million gain on divestitures of intellectual property on future earnings. Consider the company's ability to navigate federal cannabis regulations and expand its brand portfolio in a competitive market.

Financial Highlights

revenue

$864.17M

net Income

$30.95M

cash Position

$226.21M

revenue Growth

+2.5%

Revenue Breakdown

Key Numbers

• $291.37M — Net Revenues (Q3 2025) (Increased by 1.6% from $286.87M in Q3 2024)
• $864.17M — Net Revenues (9 months 2025) (Increased by 2.5% from $842.82M in 9 months 2024)
• $23.29M — Net Income Attributable to Green Thumb Industries Inc. (Q3 2025) (Increased by 170% from $8.62M in Q3 2024)
• $30.95M — Net Income Attributable to Green Thumb Industries Inc. (9 months 2025) (Decreased by 48.8% from $60.40M in 9 months 2024)
• $226.21M — Cash and Cash Equivalents (September 30, 2025) (Increased from $171.69M at December 31, 2024)
• $204.79M — Net Cash Flows Provided by Operating Activities (9 months 2025) (Increased from $151.85M in 9 months 2024)
• $29.88M — Net Gain on Divestitures of Intellectual Property (9 months 2025) (Significant one-time gain impacting net income)
• $75.63M — Investments in Securities and Associates (9 months 2025) (Increased from $7.80M in 9 months 2024, indicating strategic investments)
• $81.60M — Income Tax Payable (September 30, 2025) (Increased significantly from $2.33M at December 31, 2024)
• $102.01M — Provision For Income Taxes (9 months 2025) (Increased from $94.97M in 9 months 2024)

Key Players & Entities

• Green Thumb Industries Inc. (company) — registrant
• SEC (regulator) — Securities and Exchange Commission
• Bloomberg (company) — publisher
• U.S. Food and Drug Administration (regulator) — potential regulator of cannabis business
• U.S. Bureau of Alcohol, Tobacco Firearms and Explosives (regulator) — potential regulator of cannabis business
• &Shine (company) — cannabis consumer packaged goods brand
• RYTHM (company) — cannabis consumer packaged goods brand
• September 30, 2025 (date) — end of quarterly period
• December 31, 2024 (date) — end of previous fiscal year
• Project Remix (company) — divestiture asset

FAQ

Risk Factors

• Federal Illegality of Cannabis [high — regulatory]: The ongoing federal illegality of cannabis in the U.S. presents significant risks, impacting banking, taxation, and interstate commerce. This creates operational complexities and limits access to traditional financial services.
• Intense Competition [high — market]: Green Thumb faces intense competition from both legal state-licensed operators and the illicit market. This competition can pressure pricing and market share, requiring continuous innovation and efficient operations.
• State-Specific Regulations [medium — operational]: Operating in multiple states means navigating a complex and evolving patchwork of state-specific regulations. Non-compliance can lead to fines, license suspension, or revocation, impacting operations and profitability.
• Taxation Challenges (280E) [high — financial]: Section 280E of the U.S. Internal Revenue Code prohibits businesses from deducting ordinary business expenses, leading to a significantly higher effective tax rate for cannabis companies. This impacts net income and cash flow.

Industry Context

The U.S. cannabis industry is characterized by rapid growth, evolving state-level regulations, and intense competition. While many states have legalized cannabis for medical or adult-use, federal prohibition creates significant operational and financial hurdles. Companies like Green Thumb operate in a fragmented market, with a focus on building strong consumer brands and efficient supply chains.

Regulatory Implications

The primary regulatory challenge remains the federal illegality of cannabis in the U.S., impacting banking, taxation (Section 280E), and interstate commerce. Companies must navigate a complex and varied landscape of state-specific regulations, with strict compliance requirements to avoid penalties.

What Investors Should Do

1. [object Object]
2. [object Object]
3. [object Object]
4. [object Object]

Key Dates

• 2025-09-30: End of Q3 and Nine-Month Period — Reporting period for the financial results showing mixed net income trends and revenue growth.
• 2025-09-30: Balance Sheet Date — Indicates a strong cash position of $226.21 million, up from $171.69 million at year-end 2024.

Glossary

Net Revenues

The total revenue generated from sales after deducting returns, allowances, and discounts. (Key indicator of the company's top-line performance and market demand for its products.)

Net Income Attributable to Green Thumb Industries Inc.

The profit remaining after all expenses, taxes, and non-controlling interests have been deducted. (Measures the company's overall profitability for shareholders.)

Cash and Cash Equivalents

Highly liquid investments with maturities of three months or less at the time of purchase. (Indicates the company's short-term liquidity and financial flexibility.)

Net Cash Flows Provided by Operating Activities

The cash generated from the normal day-to-day business operations of the company. (Shows the company's ability to generate cash from its core business, a crucial sign of financial health.)

Net Gain on Divestitures of Intellectual Property

Profit realized from selling off intellectual property assets. (A one-time gain that significantly boosted net income for the nine-month period, not indicative of ongoing operational performance.)

Investments in Securities and Associates

Funds allocated to purchasing stocks, bonds, or stakes in other companies. (Indicates strategic capital allocation and potential future growth drivers or diversification.)

Income Tax Payable

The amount of income tax owed to tax authorities but not yet paid. (A significant increase suggests potential changes in tax strategy, liabilities, or cash management related to taxes.)

Provision For Income Taxes

The amount of income tax expense recognized in the financial statements for a given period. (Reflects the company's tax burden, which can be high for cannabis companies due to Section 280E.)

Year-Over-Year Comparison

Compared to the prior year's comparable periods, Green Thumb Industries Inc. shows modest revenue growth for both the third quarter (+1.6%) and the nine-month period (+2.5%). However, net income performance is mixed, with a substantial 170% increase in Q3 2025 but a significant 48.8% decrease for the nine months ended September 30, 2025, partly due to a one-time gain on divestitures in the current period. The company has strengthened its cash position considerably, and operating cash flow has seen a robust increase, indicating improved operational cash generation.

Filing Documents

• gtbif-20250930.htm (10-Q) — 2380KB
• gtbif-ex31_1.htm (EX-31.1) — 15KB
• gtbif-ex31_2.htm (EX-31.2) — 15KB
• gtbif-ex32_1.htm (EX-32.1) — 7KB
• gtbif-ex32_2.htm (EX-32.2) — 7KB
• img170787106_0.jpg (GRAPHIC) — 8KB
• 0001193125-25-266987.txt ( ) — 10740KB
• gtbif-20250930.xsd (EX-101.SCH) — 1764KB
• gtbif-20250930_htm.xml (XML) — 1915KB

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 28 ITEM 3: Quantitative and Qualitative Disclosure About Market Risk 37 ITEM 4:

Controls and Procedures

Controls and Procedures 37 OTHER INFORMATION ITEM 1:

Legal Proceedings

Legal Proceedings 38 ITEM 1A:

Risk Factors

Risk Factors 38 ITEM 2: Unregistered Sales of Equity Securities and Use of Proceeds 38 ITEM 3: Defaults Upon Senior Securities 39 ITEM 4: Mine Safety Disclosures 40 ITEM 5: Other Information 40 ITEM 6: Exhibits 41

Signatures

Signatures 42 Use of Names In this Quarterly Report on Form 10-Q, unless the context otherwise requires, the terms "we," "us," "our," "Company," "Corporation" or "Green Thumb" refer to Green Thumb Industries Inc. together with its wholly-owned subsidiaries. Currency Unless otherwise indicated, all references to "$" or "US$" in this document refer to United States dollars, and all references to "C$" refer to Canadian dollars. Disclosure Regarding Forward-Looking Statements This Quarterly Report on Form 10-Q contains statements that we believe are, or may be considered to be, "forward-looking statements." All statements other than statements of historical fact included in this document regarding the prospects of our industry or our prospects, plans, financial position or business strategy may constitute forward-looking statements. In addition, forward-looking statements generally can be identified by the use of forward-looking words such as "may," "will," "expect," "intend," "estimate," "foresee," "project," "anticipate," "believe," "plan," "forecast," "continue" or "could" or the negative of these terms or variations of them or similar terms or expressions of similar meaning. Furthermore, forward-looking statements may be included in various filings that we make with the Securities and Exchange Commission (the "SEC"), and in press releases or oral statements made by or with the approval of one of our authorized executive officers. Although we believe that the expectations reflected in these forward-looking statements are reasonable, we cannot assure you that these expectations will prove to be correct. These forward-looking statements are subject to certain known and unknown risks and uncertainties, as well as assumptions that could cause actual results to differ materially from those reflected in these forward-looking statements. These known and unknown risks include, without limitation: cannabis remains illegal under U.S. federal law, and enforcement